Home LiteratureArticle Details
PMID: 15194763 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins.

Journal of virology ·Vol. 78 ·No. 13 ·2004-07-00 ·Pages 6875-82

Flint M, Logvinoff C, Rice CM, McKeating JA

Abstract

The recent development of infectious retroviral pseudotypes bearing hepatitis C virus (HCV) glycoproteins represents an opportunity to study the functionally active form of the HCV E1 and E2 glycoproteins. In the culture supernatant of cells producing HCV retroviral pseudotypes, the majority of E2 was not associated with infectious particles and failed to sediment on sucrose gradients. The E2 that was incorporated into infectious particles appeared as a triplet of diffuse bands at 60, 70, and 90 kDa. Similarly, three major forms of E1 were incorporated into the pseudotype particles, migrating at 33, 31, and 25 kDa. Endoglycosidase H (endo-H) treatment of particles demonstrated that the incorporated E1 was partially or completely sensitive to digestion. In contrast, the majority of the incorporated E2 was endo-H resistant. Purified pseudotype particles were found to contain both disulfide-linked aggregates and nonaggregated E1 and E2. HCV pseudotypes generated from cells expressing E1E2p7 showed similar heterogeneity in the incorporated glycoproteins and were of comparable infectivity to those generated by expression of E1E2. Our results demonstrate the heterogeneous nature of E1 and E2 incorporated into retroviral pseudotypes and highlight the difficulty in identifying forms of the HCV glycoproteins that initiate infection.

MeSH Terms
Animals Cell Line HIV/genetics,metabolism Hepacivirus/genetics,metabolism Humans Plasmids/genetics Rats Transfection Viral Envelope Proteins/genetics,metabolism Viral Structural Proteins/genetics,metabolism Virion/metabolism,pathogenicity
Chemicals
Viral Envelope Proteins Viral Structural Proteins protein E1, Classical swine fever virus glycoprotein E2, Hepatitis C virus
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Flint Mike
The Center for the Study of Hepatitis C, The Rockefeller University, New York, NY 10021, USA.
Logvinoff Carine
Rice Charles M
McKeating Jane A
References (33)
33 references, click to expand
  1. The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences.
    Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11646-51 PMID: 14504405
  2. Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins.
    FEBS Lett. 2003 Jul 10;546(2-3):385-90 PMID: 12832074
  3. Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1.
    J Virol. 2003 Dec;77(24):13418-24 PMID: 14645599
  4. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
    J Virol. 2004 Feb;78(3):1448-55 PMID: 14722300
  5. Uncleaved NS2-3 is required for production of infectious bovine viral diarrhea virus.
    J Virol. 2004 Mar;78(5):2414-25 PMID: 14963137
  6. Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport.
    J Virol. 1994 Feb;68(2):911-9 PMID: 7507186
  7. Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein.
    J Virol. 1994 Feb;68(2):920-6 PMID: 8289394
  8. Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini.
    J Virol. 1994 Aug;68(8):5063-73 PMID: 7518529
  9. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses.
    J Virol. 1994 Oct;68(10):6147-60 PMID: 8083956
  10. Two hepatitis C virus glycoprotein E2 products with different C termini.
    J Virol. 1994 Oct;68(10):6215-22 PMID: 8083961
  11. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.
    Virology. 1995 Feb 1;206(2):935-44 PMID: 7531918
  12. Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin.
    J Virol. 1996 Feb;70(2):778-86 PMID: 8551615
  13. Interaction between hepatitis C virus core protein and E1 envelope protein.
    J Virol. 1996 Aug;70(8):5177-82 PMID: 8764026
  14. Formation of native hepatitis C virus glycoprotein complexes.
    J Virol. 1997 Jan;71(1):697-704 PMID: 8985401
  15. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2.
    J Virol. 1998 Mar;72(3):2183-91 PMID: 9499075
  16. Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins.
    J Virol. 1998 May;72(5):3851-8 PMID: 9557669
  17. Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval.
    J Biol Chem. 1998 Nov 27;273(48):32088-95 PMID: 9822684
  18. The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum.
    J Virol. 1999 Apr;73(4):2641-9 PMID: 10074109
  19. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.
    J Virol. 1999 Aug;73(8):6235-44 PMID: 10400713
  20. The C-terminal region of the hepatitis C virus E1 glycoprotein confers localization within the endoplasmic reticulum.
    J Gen Virol. 1999 Aug;80 ( Pt 8):1943-7 PMID: 10466789
  21. Folding, assembly and subcellular localization of hepatitis C virus glycoproteins.
    Curr Top Microbiol Immunol. 2000;242:135-48 PMID: 10592659
  22. A new determinant of endoplasmic reticulum localization is contained in the juxtamembrane region of the ectodomain of hepatitis C virus glycoprotein E1.
    J Biol Chem. 2000 Aug 4;275(31):24070-9 PMID: 10783397
  23. Coexpression of hepatitis C virus envelope proteins E1 and E2 in cis improves the stability of membrane insertion of E2.
    J Gen Virol. 2001 Jul;82(Pt 7):1629-35 PMID: 11413374
  24. Biogenesis of hepatitis C virus envelope glycoproteins.
    J Gen Virol. 2001 Nov;82(Pt 11):2589-95 PMID: 11602769
  25. Subcellular localization and topology of the p7 polypeptide of hepatitis C virus.
    J Virol. 2002 Apr;76(8):3720-30 PMID: 11907211
  26. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture.
    J Virol. 2002 Apr;76(8):4008-21 PMID: 11907240
  27. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles.
    J Virol. 2002 May;76(10):4773-84 PMID: 11967294
  28. Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies.
    J Virol. 2003 Jan;77(1):353-65 PMID: 12477840
  29. The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine.
    FEBS Lett. 2003 Jan 30;535(1-3):34-8 PMID: 12560074
  30. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.
    J Exp Med. 2003 Mar 3;197(5):633-42 PMID: 12615904
  31. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives.
    Proc Natl Acad Sci U S A. 2003 May 13;100(10):6104-8 PMID: 12719519
  32. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles.
    Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7271-6 PMID: 12761383
  33. Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope.
    J Biol Chem. 2003 Nov 7;278(45):44385-92 PMID: 12882983
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-07-00
Pages
6875-82
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC421632
Subset
IM
Grants
NCI NIH HHS · R01 CA057973 · United States
NCI NIH HHS · CA57973 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com